W Amy Schulman

Affiliations

  • at Fractyl Health Inc. (GUTS), 2024-02-05
  • Large Shareholder, Director at Sqz Biotechnologies Co (SQZ), 2023-06-15
  • Director at Alnylam Pharmaceuticals Inc. (ALNY), 2023-05-19
  • Director at Hudson Executive Investment Corp. Ii (HCII), 2021-04-14
  • Director at Cyclerion Therapeutics Inc. (CYCN), 2020-06-18
  • Director at Hudson Executive Investment Corp. (HEC), 2020-06-08
  • Director at Ironwood Pharmaceuticals Inc (IRWD), 2019-04-03
  • Director at Arsanis Inc. (ASNS), 2018-06-07
  • Director at Blue Buffalo Pet Products Inc. (BUFF), 2018-04-24
  • Director at Bind Therapeutics Inc (BIND), 2015-06-10
  • Former Exec. Vice President at Pfizer Inc (PFE), 2014-01-03
  • Director at Zoetis Inc. (ZTS), 2013-02-08
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SQZ $10.94 1,850 Large Shareholder, Director 1,850 2021-12-13 Filing
SQZ $10.88 1,850 Large Shareholder, Director 1,850 2021-12-13 Filing
SQZ $16.00 233,654 Large Shareholder, Director 2,549,306 2020-11-03 Filing
SQZ $16.00 16,346 Large Shareholder, Director 178,340 2020-11-03 Filing
CYCN $16.00 21,635 Director 21,635 2019-04-08 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PFE $29.35 10,598 Officer 223,497 2013-05-15 Filing
PFE $29.41 10,408 Officer 234,095 2013-05-15 Filing
PFE $29.32 5,700 Officer 244,503 2013-05-15 Filing
PFE $29.34 5,268 Officer 250,203 2013-05-15 Filing
PFE $29.40 4,701 Officer 255,471 2013-05-15 Filing